VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma.
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J. 2000 May-Jun; 6(3):139-45.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Chemotherapy, Adjuvant
Clinical Trials as Topic
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Head and Neck Neoplasms
Humans
Interferon-alpha
Lymphatic Metastasis
Male
Melanoma
Middle Aged
Recombinant Proteins
Retrospective Studies
Risk Factors
Skin Neoplasms
Time Factors
authors with profiles
ERIC JONASCH